Douglas Delgrosso Buys Shares of Cabot Corporation
Douglas Delgrosso purchased 28 shares of Cabot Corporation, valued at $2,454.20.
Key Points
- Douglas Delgrosso bought 28 shares of Cabot Corporation at $87.65 each, totaling $2,454.20 on June 12, 2026.
- Cabot Corporation's stock traded at $89.21 with a market cap of $4.61 billion and a P/E ratio of 16.5.
- Institutional investors like BlackRock and Wellington Management adjusted their Cabot positions recently.
Douglas Delgrosso, an insider at Cabot Corporation, recently purchased 28 shares of the company. This transaction took place on June 12, 2026, with each share bought at $87.65, amounting to a total value of $2,454.20.
Insider Buying and Selling at Cabot Corporation
On the same day, other insiders also bought shares of Cabot Corporation. Sean Keohane, the President and CEO, acquired 256 shares, while Erica McLaughlin, the Executive Vice President and CFO, purchased 55 shares. All these transactions were made at the same price of $87.65 per share, without any indication of being part of a pre-planned trading program.
Other Institutional Activity in Cabot Corporation
Several large funds have also been active in Cabot Corporation's stock. BlackRock, Inc. slightly trimmed its holdings by 8,938 shares, ending with 6,616,051 shares valued at about $498.3 million. Wellington Management Group reduced its stake by 185,397 shares, leaving it with 3,566,172 shares worth approximately $268.6 million. Meanwhile, Earnest Partners LLC increased its holdings by 52,703 shares, bringing their total to 3,158,617 shares valued at around $237.9 million.
Cabot Corporation Stock Snapshot
Shares of Cabot Corporation (NYSE:CBT) recently traded at $89.21. The company has a market capitalization of approximately $4.61 billion. Its P/E ratio stands at 16.5, with a forward P/E of about 12.7. The stock's 52-week range is between $58.33 and $89.46, and it has a beta of 0.829, indicating lower volatility compared to the market. The company's 50-day moving average is $80.22, while the 200-day moving average is $73.31.
Recent Earnings
Cabot Corporation reported revenue of $3.58 billion, reflecting a slight decline of 3.4%. The company's earnings per share (EPS) is $5.4, with a net margin of 7.97% and a return on equity (ROE) of 19.96%. The next earnings report is scheduled for August 3, 2026.
Dividend
Cabot Corporation pays an annual dividend rate of $1.82, yielding 2.04%. The dividend payout ratio is 33.96%, indicating a sustainable dividend policy.
Analysts Set New Price Targets
On June 8, 2026, Truist Securities initiated coverage on Cabot Corporation with a "buy" rating and set a price target of $98. Meanwhile, JP Morgan maintained a "sell" rating with a $70 target on May 13, 2026. UBS and Mizuho have maintained "hold" ratings with targets of $86 and $80, respectively. The consensus among analysts is a "buy" recommendation, with an average target price of $85.67 based on six opinions.
About Cabot Corporation
Cabot Corporation is a specialty chemicals company headquartered in Boston, Massachusetts. Founded in 1882, it operates in the basic materials sector, specifically in specialty chemicals. The company is led by CEO Sean D. Keohane and employs over 4,000 people. Cabot's products include reinforcing carbons used in tires, specialty carbons for inks and coatings, and performance materials for various industrial applications. It serves a global market through its Reinforcement Materials and Performance Chemicals segments.
Bottom Line
Douglas Delgrosso's purchase of Cabot Corporation shares adds to a recent flurry of insider buying activity. Investors often track such insider transactions for potential insights into company prospects. It's important to note that these filings are typically backward-looking and might not reflect the current position of the insiders. Cabot's stock remains a focus for institutional investors and analysts alike, with varying opinions on its future performance.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.
